MMQ0:FRA
Definium Therapeutics Inc
€33.60
arrow_upward
+0.60%(+0.20) 1D
Sep 21, 10:00:00 PM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MMQ0...
Open
€32.80
High
€34.10
Low
€32.80
Mkt. cap
5.28B
Avg. vol.
54.00
Volume
5.00
52-wk high
€42.70
52-wk low
€12.81
No. of employees
106
Open
€32.80
High
€34.10
Low
€32.80
Mkt. cap
5.28B
Avg. vol.
54.00
Volume
5.00
52-wk high
€42.70
52-wk low
€12.81
No. of employees
106
News stories
From web sources and news partners
Simply Wall Street
·
2 days ago
Definium Therapeutics (DFTX) Posts Another Positive Phase 3, Is The Stock Still A Bargain?
CarePlus VietNam
·
2 months ago
Definium Therapeutics Edges Higher Amid Cautious Trading – DFTX Holds Near Support - Retail Sentiment
Profile
Definium Therapeutics, Inc., formerly known as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs. Wikipedia
About Definium Therapeutics Inc
CEORobert Barrow
Employees106
Founded2010
Headquarters-
SectorPharmaceutical industry
Websitedefiniumtx.com